Related references
Note: Only part of the references are listed.Proton pump inhibitors and risk of gastric cancer: population-based cohort study
Devin Abrahami et al.
GUT (2022)
Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea
Seung In Seo et al.
GUT (2021)
Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors
Elizabeth M. Salvo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
When does proton pump inhibitor treatment become long term? A scoping review
Peter Fentz Haastrup et al.
BMJ OPEN GASTROENTEROLOGY (2021)
Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population
Jeffrey K. Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
Peipei Liu et al.
BRITISH JOURNAL OF CANCER (2020)
Autoimmune gastritis
Marco Vincenzo Lenti et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Autoimmune Gastritis and Gastric Microbiota
Laura Conti et al.
MICROORGANISMS (2020)
Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD
Yen-Chun Peng et al.
GUT (2019)
Proton pump inhibitors and risk of gastric cancer in a case-control study
Shih-Wei Lai et al.
GUT (2019)
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019
Pedro Pimentel-Nunes et al.
ENDOSCOPY (2019)
Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]
Edith Lahner et al.
DIGESTIVE AND LIVER DISEASE (2019)
Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis
Ryota Niikura et al.
GUT (2018)
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
Ka Shing Cheung et al.
GUT (2018)
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal
Vincenzo Savarino et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2017)
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Daniel S. Strand et al.
GUT AND LIVER (2017)
Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use
Bryony N. Parsons et al.
PLOS PATHOGENS (2017)
ACG and CAG Clinical Guideline: Management of Dyspepsia
Paul M. Moayyedi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors
J. L. Schneider et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression
Carmelo Scarpignato et al.
BMC MEDICINE (2016)
Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology
L. Lundell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up
Edith Lahner et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
Erik von Elm et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Common Features of Patients With Autoimmune Atrophic Gastritis
Emanuela Miceli et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)
M. Dinis-Ribeiro et al.
ENDOSCOPY (2012)
Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency
Edith Lahner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia
G Qvigstad et al.
APMIS (2002)
Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment
E Lahner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
